Goldman Sachs Group, Inc. (The) set a CHF 80 target price on Novartis AG (VTX:NOVN) in a report released on Friday morning. The brokerage currently has a neutral rating on the stock.

A number of other analysts have also weighed in on the stock. Barclays PLC set a CHF 65 target price on shares of Novartis AG and gave the company a sell rating in a research report on Friday, June 2nd. Deutsche Bank AG set a CHF 78 target price on shares of Novartis AG and gave the company a neutral rating in a research report on Wednesday, June 21st. Morgan Stanley set a CHF 75 target price on shares of Novartis AG and gave the company a sell rating in a research report on Monday, May 29th. Jefferies Group LLC set a CHF 103 target price on shares of Novartis AG and gave the company a buy rating in a research report on Friday, June 23rd. Finally, HSBC Holdings plc set a CHF 85 target price on shares of Novartis AG and gave the company a buy rating in a research report on Wednesday, June 21st. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company currently has an average rating of Hold and an average price target of CHF 82.30.

Novartis AG (VTX:NOVN) traded up 0.31% on Friday, reaching CHK 80.15. The company’s stock had a trading volume of 3,795,292 shares. Novartis AG has a 12 month low of CHK 67.40 and a 12 month high of CHK 84.35. The firm’s 50 day moving average is CHK 79.68 and its 200-day moving average is CHK 75.84.

TRADEMARK VIOLATION NOTICE: This piece was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/07/17/novartis-ag-novn-given-a-chf-80-price-target-at-goldman-sachs-group-inc-the.html.

Novartis AG Company Profile

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company’s segments include Innovative Medicines, Sandoz, Alcon and Corporate activities.

Analyst Recommendations for Novartis AG (VTX:NOVN)

Receive News & Ratings for Novartis AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novartis AG and related companies with MarketBeat.com's FREE daily email newsletter.